What is AbCellera Biologics Inc.'s dividends cash?

AbCellera Biologics Inc. (ABCL) reported dividends cash of $0 in Q4 2025.

What does dividends cash mean?

The total cash outflow paid to shareholders as a distribution of company earnings. This reflects the company's capital allocation policy regarding returning excess cash to investors versus reinvesting in operations.

AbCellera Biologics Inc. ABCL Dividends Cash

Dividends Cash at other companies

TFX

TeleflexTFX

$15.1M-1.0%

NWN

Northwest NaturalNWN

$20.11M+6.0%

AbCellera Biologics Inc.ABCL

$0—

Schneider NationalSNDR

$17.6M+4.8%

TFS FinancialTFSL

$15.19M+1.5%

National Fuel GasNFG

$50.84M+9.2%

Other financials

Income statement

See full

Revenue$8.3M+96.3%

Operating income-$57.5M+8.2%

Net income-$43.2M+5.4%

EPS (diluted)-$0.14+6.7%

Balance sheet

See full

Cash & equivalents$102.1M-44.6%

Total debt$140.2M+107%

Total equity$938.1M-8.3%

Total assets$1.3B-2.8%

Cash flow

See full

Operating cash flow-$33.5M-190%

CapEx$3.8M-64.0%

Free cash flow-$37.4M-68.3%

Valuation

See full

Market cap$1.72B+59.2%

Enterprise value$1.76B+100.0%

P/S21.7×-25.0×

Profitability

See full

Operating margin-267.6%-120pp

Net margin-181.7%-77.9pp

FCF margin-238.9%-90.9pp

Returns & leverage

See full

Return on equity-14.7%-0.8pp

Debt / equity0.1×+0.1×

Current ratio14.1×+3.9×

Where this comes from

Reported directly by AbCellera Biologics Inc. in its filing.

Tagged under the XBRL concept us-gaap:DividendsCash.

The official record: AbCellera Biologics Inc.’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbCellera Biologics Inc.'s dividends cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AbCellera Biologics Inc.'s dividends cash?: AbCellera Biologics Inc. (ABCL) reported dividends cash of $0 in Q4 2025.
What does dividends cash mean?: The total cash outflow paid to shareholders as a distribution of company earnings. This reflects the company's capital allocation policy regarding returning excess cash to investors versus reinvesting in operations.